Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARTLifeLine: Assisted Reproduction Technology (ART) Family Health and Development Trajectory Cohort (ARTLL)

NCT06786871 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT06786871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06786871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARTLifeLine: Assisted Reproduction Technology (ART) Family Health and Development Trajectory Cohort (ARTLL)
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 20, 2025
Completion date
December 31, 2043
Enrollment
100,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cohort studies, development, infant, family, reproductive issues, reproductive techniques, assisted